Lanreotide Acetate
Price | USD3.00 |
Packge | 3KG |
- Min. Order:1KG
- Supply Ability:100kg
- Time:2019-07-12
Product Details
- Product NameLanreotide Acetate
- CAS No.127984-74-1
- MFC54H69N11O10S2
- MW0
- Appearancepowderwhite to off-white
- storage temp. -20°C
- Melting point >165°C (dec.)
Lanreotide Acetate Basic information |
Product Name: | Lanreotide Acetate |
Synonyms: | 10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide;Somatulina;LANREOTIDE ACETATE;3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2→7)-disulfide acetate;Angiopeptin acetate |
CAS: | 127984-74-1 |
MF: | C54H69N11O10S2 |
MW: | 0 |
EINECS: | |
Product Categories: | Amino Acids & Derivatives, Pharmaceuticals, Intermediates & Derivatives |
Mol File: | 127984-74-1.mol |
Lanreotide Acetate Chemical Properties |
storage temp. | ?20°C |
form | powder |
color | white to off-white |
Lanreotide Acetate Usage And Synthesis |
Description | Lanreotide acetate, an octapeptide somatostatin analog, reached its first worldwide market in France for acromegaly when surgery or radiotherapy have failed to restore normal growth hormone secretion. Lanreotide is a selective inhibitor of growth hormone and reduces the secretion of growth hormone, thyrotropin, motilin and pancreatic polypeptide in humans. Lanreotide has antiproliferative properties and is reportedly in clinical trials for the prevention of restenosis following coronary artery angioplasty, for diabetic retinopathy, and as a therapy for psoriasis. Its potential for neuroendocrine tumors and hormone-responsive prostate cancer has also been demonstrated. |
Originator | Beaufour-Ipsen (France) |
Uses | Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma. |
Brand name | Somatuline LP |
Company Profile Introduction
Henan CoreyChem Co., Ltd, based on the original Zhengzhou Cote Chemical Research Institute, be brave in absorbing highly educated talents & overseas returnees; actively responded to Zhengzhou City High-tech Zone Government’s Special Care Policy, reorganized and founded in National University of Science and Technology Park, which is a high-tech, stock enterprise of high-end chemical Custom synthesis;The park was created by the People's Government of Henan Province, and proved by Ministry of Education and the National Science & Technology, taking the construction mode of "many college a park, and common development", mainly depends on Zhengzhou University and Henan University’s scientific research and talent advantage to set up Universities, scientific research institute and enterprise scientific research achievements transformation platform, to make high-tech enterprises incubate, is the new high-tech talent gathering base, high and new technology industry enterprise radiation base, colleges and universities technological innovation base.
Henan Coreychem Co., Ltd, facing global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade. Corey have well-equipped machine, strong technical force and considerate marketing team service. We also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.
Recommended supplier
-
VIP1年
- Apicore Pharmaceuticals Pvt Ltd
- 127984-74-1 98%
- Inquiry
- 2024-03-07
-
VIP1年
- Apicore Pharmaceuticals Pvt Ltd
- 108736-35-2 Lanreotide 98%
- Inquiry
- 2024-03-07
- Since:2014-12-17
- Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY